Nortech Systems Inc. 10-K Summary (Fiscal Year Ended Dec 31, 2001)
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2001, for Nortech Systems Inc., a Minnesota-based contract manufacturer. The Company provides "turnkey" manufacturing services, including wire harnesses, cables, electronic sub-assemblies, and printed circuit board assemblies. Operations are concentrated in the Contract Manufacturing segment following the discontinuation of Display Products and Medical Management segments in 1999 and 2000. Major customers include G.E. Medical Systems, Raytheon, and Kodak.
Key Financial Metrics
| Metric | 2001 | 2000 |
|---|---|---|
| Net Sales | $58,460,589 | $54,775,279 |
| Gross Profit | $10,446,345 | $10,267,790 |
| Gross Margin | 17.9% | 18.7% |
| Net Income (Continuing Ops) | $2,102,863 | $2,043,573 |
| Diluted EPS | $0.86 | $0.83 |
| Operating Cash Flow | $1,049,870 | $855,040 |
| Total Assets | $29,507,538 | $28,652,949 |
| Total Long-Term Debt | $9,791,722 | $7,665,536 |
| Working Capital | $14,459,344 | $9,633,539 |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased by 6.8% ($3.7 million) driven by internal growth within the medical and defense industries.
- Profitability: Net income from continuing operations rose 2.9% to $2.1 million. Gross margin declined slightly from 18.7% to 17.9% due to competitive pricing pressures.
- Expense Management: General and Administrative expenses decreased by approximately $638,000 (15.9%) due to cost-cutting measures and reduced administrative staff. Selling expenses increased by 30% due to expanded sales force and commissions.
- Liquidity: Working capital improved significantly from $9.6 million to $14.5 million, aided by a debt refinancing completed in January 2002.
- Debt Structure: Long-term debt increased by $2.1 million. The Company refinanced the majority of its debt with Wells Fargo Bank in January 2002, restructuring it into term notes and an $8 million revolving line of credit.
Guidance, Outlook, and Risks
Outlook: Management expects revenue growth to continue at a moderate rate for 2002. The Company anticipates meeting future financial requirements through operating cash flows and its operating line of credit.
Risks and Contingencies:
- Customer Concentration: G.E. Medical accounted for 24% of total sales in 2001. One customer also represented 17% of accounts receivable.
- Competition: The Company faces significant competition from foreign manufacturers offering lower prices and improved technical support.
- Interest Rate Risk: The Company has variable rate borrowings; however, management estimates a 10% change in interest rates would not materially affect earnings.
- Discontinued Operations: While the Display Products and Medical Management segments were sold or classified as discontinued, residual liabilities and assets remain on the balance sheet.
Investor Verification Checklist
- Verify the sustainability of the 24% revenue concentration with G.E. Medical Systems.
- Confirm the terms and covenants of the January 2002 debt refinancing with Wells Fargo Bank.
- Monitor the trend in gross margins, which declined to 17.9% amidst competitive pricing pressures.
- Review the status of the remaining assets and liabilities associated with the discontinued Medical Management segment.
- Assess the impact of foreign competition on future pricing power and market share.